Targeting EXT1 reveals a crucial role for heparan sulfate in the growth of multiple myeloma.
about
Heparan sulfate proteoglycans in the control of B cell development and the pathogenesis of multiple myelomaSecondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXTEXTra hit for mouse osteochondroma.Tracking human multiple myeloma xenografts in NOD-Rag-1/IL-2 receptor gamma chain-null mice with the novel biomarker AKAP-4SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis.The glycome of normal and malignant plasma cellsD-glucuronyl C5-epimerase suppresses small-cell lung cancer cell proliferation in vitro and tumour growth in vivo.Epiphyseal growth plate and secondary peripheral chondrosarcoma: the neighbours matter.Glycosaminoglycans: key players in cancer cell biology and treatment.Targeting syndecans: a promising strategy for the treatment of cancer.N-cadherin-mediated interaction with multiple myeloma cells inhibits osteoblast differentiation.Strychnos nux-vomica root extract induces apoptosis in the human multiple myeloma cell line-U266B1.Syndecan-1 promotes the angiogenic phenotype of multiple myeloma endothelial cells.Exostosin 1 regulates cancer cell stemness in doxorubicin-resistant breast cancer cells.Extracellular matrix: The driving force of mammalian diseases.Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential.
P2860
Q27001749-2106CFB8-09C2-40B7-B558-1413CF134F4DQ28244569-11A8CE67-94E5-4DBB-B946-F0A34C46202FQ33720003-BA50316E-508D-476C-9AAE-C568B5E43C7FQ34020937-DC0DA1A9-FDC2-46AA-87CD-4930EE523B67Q34694466-6EE3B071-9585-4519-86D6-A85326D9048CQ35080602-B1AC9219-3A2D-408C-BE08-657C2040AD91Q35108319-A893FA92-B738-48D1-B2A2-DCA1EE928B4EQ37940373-729AA3F0-C4A4-4C94-930C-27E55C4EDC9DQ37983930-86981E71-F403-416D-A578-8E65E25CB61EQ38082795-828E7D74-62EA-4236-AC3B-A82AB676B135Q38949755-4FC9BEF2-B186-43CD-81F8-5FC9611977FCQ39224279-C29C800F-4871-42FE-8138-6D2A11CDA7BAQ42064478-598C1DF0-3522-4A9C-A283-B5322D9F7F1DQ42378449-BC43B5F6-0D89-41BC-BBB2-2A1E70B80150Q52602287-077DA71A-D591-46C6-A881-DA8389557E1DQ54956715-4DB52E71-224B-454F-9041-B1D9D4E5B3A2
P2860
Targeting EXT1 reveals a crucial role for heparan sulfate in the growth of multiple myeloma.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Targeting EXT1 reveals a cruci ...... he growth of multiple myeloma.
@en
Targeting EXT1 reveals a cruci ...... he growth of multiple myeloma.
@nl
type
label
Targeting EXT1 reveals a cruci ...... he growth of multiple myeloma.
@en
Targeting EXT1 reveals a cruci ...... he growth of multiple myeloma.
@nl
prefLabel
Targeting EXT1 reveals a cruci ...... he growth of multiple myeloma.
@en
Targeting EXT1 reveals a cruci ...... he growth of multiple myeloma.
@nl
P2093
P50
P1433
P1476
Targeting EXT1 reveals a cruci ...... the growth of multiple myeloma
@en
P2093
Anneke de Haan-Kramer
Annemieke Kuil
Anton C M Martens
Henk Rozemuller
Steven T Pals
Tamás Csikós
P304
P356
10.1182/BLOOD-2009-02-204396
P407
P577
2009-11-13T00:00:00Z